カテゴリー： Research Dive, 世界, 医療/バイオ

外傷性脳損傷（TBI）分析の世界市場2022-2031：機会分析・産業予測

◆英語タイトル：Traumatic Brain Injuries Assessment Market, by End-user (Hospital, Diagnostics Center, and Others) and Diagnostic Type (CT-Scan, MRI, Electronics, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2), and Others) Global Opportunity Analysis and Industry Forecast, 2022-2031
	◆商品コード：RDV23MA025 ◆発行会社（リサーチ会社）：Research Dive ◆発行日：2022年12月13日 ◆ページ数：250 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：生命科学

◆販売価格オプション（消費税別）

Single User	USD5,700 ⇒換算￥866,400	見積依頼/購入/質問フォーム
5 User	USD8,700 ⇒換算￥1,322,400	見積依頼/購入/質問フォーム
Enterprise User	USD10,700 ⇒換算￥1,626,400	見積依頼/購入/質問フォーム

★Research Diveに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

リサーチ・ダイブ社では、世界の外傷性脳損傷（TBI）分析市場規模が2021年9,570百万ドルから2031年には18,373.6百万ドルになり、年平均7%成長すると推測しています。本調査報告書では、外傷性脳損傷（TBI）分析の世界市場について多面的に調べ、調査手法、調査範囲、エグゼクティブサマリー、市場概要、エンドユーザー別（病院、診断センター、その他）分析、診断種類別（CTスキャン、MRI、電子機器、頭蓋内圧モニタリング、脳組織酸素分圧（pBrO2）、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの内容を掲載しています。尚、企業情報として、Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.などが記載されています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の外傷性脳損傷（TBI）分析市場規模：エンドユーザー別
- 病院における市場規模
- 診断センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の外傷性脳損傷（TBI）分析市場規模：診断種類別
- CTスキャンの市場規模
- MRIの市場規模
- 電子機器の市場規模
- 頭蓋内圧モニタリンの市場規模
- その他診断の市場規模
・世界の外傷性脳損傷（TBI）分析市場規模：地域別
- 北米の外傷性脳損傷（TBI）分析市場規模
- ヨーロッパの外傷性脳損傷（TBI）分析市場規模
- アジア太平洋の外傷性脳損傷（TBI）分析市場規模
- 中南米の外傷性脳損傷（TBI）分析市場規模
- 中東/アフリカの外傷性脳損傷（TBI）分析市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global traumatic brain injuries assessment market is anticipated to generate a revenue of $18,373.6 million by 2031, growing from $9,570 million in 2021, at a healthy CAGR of 7%.

COVID-19 Impact on the Traumatic Brain Injuries Assessment Market:
Nearly every business was impacted by the global public health emergency due to the COVID-19 pandemic. The long-term impacts are expected to have an influence on industry growth during the forecast period. In order to assure the inclusion of underlying COVID-19 concerns and potential future directions, the continuous study expands upon the research approach. The report provides information on COVID-19 taking into account changes in consumer demand & behavior, buying habits, supply chain rerouting, dynamics of contemporary market forces, and significant government initiatives. Insights, analyses, projections, and forecasts are provided in the updated study, which takes the market impact of COVID-19 into account.
The COVID-19 pandemic had a significant influence on scientific research related to traumatic brain injuries (TBIs). Experimental and clinical investigations either slowed down or stopped, and resources were redistributed, leading to a “lost year” for the TBI field. The pandemic can, nevertheless, act as a turning point. This study outlines the philosophical and technological lessons that can be drawn from the COVID-19 pandemic to improve the categorization, diagnostic, and treatment effectiveness of TBIs.

Traumatic Brain Injuries Assessment MarketAnalysis:
It is anticipated that the increase in TBI cases from assaults, vehicle accidents, and sports injuries will fuel market growth during the forecast period. Demand for TBI evaluation and management devices is anticipated to increase due to a growing desire for less intrusive neuro therapies, which decrease pain and infection risk as well as allow quicker recovery. The market is projected to expand as a result of the increasing number of initiatives and programs connected to brain injuries being implemented by governments around the world. For instance, the Brain Injury Association of America (BIAA) runs a national public awareness campaign each year in March to emphasize the need for addressing the impacts of brain injuries.

Poor outcomes in mild, moderate, and severe TBI in both the adult and pediatric populations are linked to a number of variables. These elements can be divided into two categories: Those that are fixed at the time of the injury and those that are intervenable (i.e., secondary injuries). The latter cannot be affected by care received later, although the former offers predictive information.

TBI affects 2% of the population in Canada and accounts for 18,000 hospital admissions each year, according to the most recent statistics provided by Brain Injury Canada. In addition, according to the same source and data as above, In Canada, TBI affects 500 people out of every 100,000 people each year, or approximately165,000 people. 456 people are harmed every day, which means one person in every three minutes. The prevalence of TBIs is rising, which is increasing the need for TBI assessment tools. These factors will boost the market’s overall growth during the forecast period.

On the basis of end-user, the hospital segment is predicted to show the fastest growth rate. Professional neurologists use high-tech equipment in hospitals, which is anticipated to accelerate the segment’s expansion during the forecast period.
On the basis of diagnostic type, CT-Scan is expected to be the most dominant segment. A CT scan can immediately identify fractures and reveal signs of bleeding (hemorrhage), blood clots (hematomas), bruised (contusions), and swollen (edema) brain tissue.
On the basis of region, North America is growing due to the presence of well-established healthcare facilities and the availability of the latest treatment procedures region’s existence of reputable medical institutions, growing government initiatives, awareness campaigns for brain injuries, and a high prevalence of traumatic brain injuries.
The companies involved in the global traumatic brain injuries assessment market are Integra Lifesciences, BioDirection, Inc., Nihon Kohden Corp., Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Zagros Petrochemical Co., Koninklijke Philips N.V, Boston Scientific Corporation, and Elekta.

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global traumatic brain injuries assessment market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on traumatic brain injuries assessment market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Traumatic Brain Injuries Assessment Market Analysis, by End-User

5.1.Overview
5.2.Hospital

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region
5.2.3.Market share analysis, by country

5.3.Diagnostics Center

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region
5.3.3.Market share analysis, by country

5.4.Others

5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region
5.4.3.Market share analysis, by country

5.5.Research Dive Exclusive Insights

5.5.1.Market attractiveness
5.5.2.Competition heatmap

6.Traumatic Brain Injuries Assessment Market Analysis, by Diagnostic Type

6.1.CT-Scan

6.1.1.Definition, key trends, growth factors, and opportunities
6.1.2.Market size analysis, by region
6.1.3.Market share analysis, by country

6.2.MRI

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region
6.2.3.Market share analysis, by country

6.3.Intracranial Pressure Monitoring

6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region
6.3.3.Market share analysis, by country

6.4.Partial Pressure of Oxygen in Brain Tissue (pBrO2)

6.4.1.Definition, key trends, growth factors, and opportunities
6.4.2.Market size analysis, by region
6.4.3.Market share analysis, by country

6.5.Others

6.5.1.Definition, key trends, growth factors, and opportunities
6.5.2.Market size analysis, by region
6.5.3.Market share analysis, by country

6.6.Research Dive Exclusive Insights

6.6.1.Market attractiveness
6.6.2.Competition heatmap

7.Traumatic Brain Injuries Assessment Market, by Region

7.1.North America

7.1.1.U.S.

7.1.1.1.Market size analysis, by End-User
7.1.1.2.Market size analysis, by Diagnostic type

7.1.2.Canada

7.1.2.1.Market size analysis, by End-User
7.1.2.2.Market size analysis, by Diagnostic type

7.1.3.Mexico

7.1.3.1.Market size analysis, by End-User
7.1.3.2.Market size analysis, by Diagnostic type

7.1.4.Research Dive Exclusive Insights

7.1.4.1.Market attractiveness
7.1.4.2.Competition heatmap

7.2.Europe

7.2.1.Germany

7.2.1.1.Market size analysis, by End-User
7.2.1.2.Market size analysis, by Diagnostic type

7.2.2.UK

7.2.2.1.Market size analysis, by End-User
7.2.2.2.Market size analysis, by Diagnostic type

7.2.3.France

7.2.3.1.Market size analysis, by End-User
7.2.3.2.Market size analysis, by Diagnostic type

7.2.4.Spain

7.2.4.1.Market size analysis, by End-User
7.2.4.2.Market size analysis, by Diagnostic type

7.2.5.Italy

7.2.5.1.Market size analysis, by End-User
7.2.5.2.Market size analysis, by Diagnostic type

7.2.6.Rest of Europe

7.2.6.1.Market size analysis, by End-User
7.2.6.2.Market size analysis, by Diagnostic type

7.2.7.Research Dive Exclusive Insights

7.2.7.1.Market attractiveness
7.2.7.2.Competition heatmap

7.3.Asia Pacific

7.3.1.China

7.3.1.1.Market size analysis, by End-User
7.3.1.2.Market size analysis, by Diagnostic type

7.3.2.Japan

7.3.2.1.Market size analysis, by End-User
7.3.2.2.Market size analysis, by Diagnostic type

7.3.3.India

7.3.3.1.Market size analysis, by End-User
7.3.3.2.Market size analysis, by Diagnostic type

7.3.4.Australia

7.3.4.1.Market size analysis, by End-User
7.3.4.2.Market size analysis, by Diagnostic type

7.3.5.South Korea

7.3.5.1.Market size analysis, by End-User
7.3.5.2.Market size analysis, by Diagnostic type

7.3.6.Rest of Asia Pacific

7.3.6.1.Market size analysis, by End-User
7.3.6.2.Market size analysis, by Diagnostic type

7.3.7.Research Dive Exclusive Insights

7.3.7.1.Market attractiveness
7.3.7.2.Competition heatmap

7.4.LAMEA

7.4.1.Brazil

7.4.1.1.Market size analysis, by End-User
7.4.1.2.Market size analysis, by Diagnostic type

7.4.2.Saudi Arabia

7.4.2.1.Market size analysis, by End-User
7.4.2.2.Market size analysis, by Diagnostic type

7.4.3.UAE

7.4.3.1.Market size analysis, by End-User
7.4.3.2.Market size analysis, by Diagnostic type

7.4.4.South Africa

7.4.4.1.Market size analysis, by End-User
7.4.4.2.Market size analysis, by Diagnostic type

7.4.5.Rest of LAMEA

7.4.5.1.Market size analysis, by End-User
7.4.5.2.Market size analysis, by Diagnostic type

7.4.6.Research Dive Exclusive Insights

7.4.6.1.Market attractiveness
7.4.6.2.Competition heatmap

8.Competitive Landscape

8.1.Top winning strategies, 2021

8.1.1.By strategy
8.1.2.By year

8.2.Strategic overview
8.3.Market share analysis, 2021

9.Company Profiles

9.1.Integra Life science

9.1.1.Overview
9.1.2.Business segments
9.1.3.Product portfolio
9.1.4.Financial performance
9.1.5.Recent developments
9.1.6.SWOT analysis

9.2.Bio Direction, Inc.

9.2.1.Overview
9.2.2.Business segments
9.2.3.Product portfolio
9.2.4.Financial performance
9.2.5.Recent developments
9.2.6.SWOT analysis

9.3.Nihon Kohden Corp.

9.3.1.Overview
9.3.2.Business segments
9.3.3.Product portfolio
9.3.4.Financial performance
9.3.5.Recent developments
9.3.6.SWOT analysis

9.4.Comp medics Ltd.

9.4.1.Overview
9.4.2.Business segments
9.4.3.Product portfolio
9.4.4.Financial performance
9.4.5.Recent developments
9.4.6.SWOT analysis

9.5.InfraScan, Inc.

9.5.1.Overview
9.5.2.Business segments
9.5.3.Product portfolio
9.5.4.Financial performance
9.5.5.Recent developments
9.5.6.SWOT analysis

9.6.Oculogica

9.6.1.Overview
9.6.2.Business segments
9.6.3.Product portfolio
9.6.4.Financial performance
9.6.5.Recent developments
9.6.6.SWOT analysis

9.7.Raumedic AG

9.7.1.Overview
9.7.2.Business segments
9.7.3.Product portfolio
9.7.4.Financial performance
9.7.5.Recent developments
9.7.6.SWOT analysis

9.8.Koninklijke Philips N.V,

9.8.1.Overview
9.8.2.Business segments
9.8.3.Product portfolio
9.8.4.Financial performance
9.8.5.Recent developments
9.8.6.SWOT analysis

9.9.Boston Scientific Corporation,

9.9.1.Overview
9.9.2.Business segments
9.9.3.Product portfolio
9.9.4.Financial performance
9.9.5.Recent developments
9.9.6.SWOT analysis

9.10.Elekta

9.10.1.Overview
9.10.2.Business segments
9.10.3.Product portfolio
9.10.4.Financial performance
9.10.5.Recent developments
9.10.6.SWOT analysis

10.Appendix

10.1.Parent & peer market analysis
10.2.Premium insights from industry experts
10.3.Related reports

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 外傷性脳損傷（TBI）分析の世界市場2022-2031：機会分析・産業予測(Traumatic Brain Injuries Assessment Market, by End-user (Hospital, Diagnostics Center, and Others) and Diagnostic Type (CT-Scan, MRI, Electronics, Intracranial Pressure Monitoring, Partial Pressure of Oxygen in Brain Tissue (pBrO2), and Others) Global Opportunity Analysis and Industry Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

外傷性脳損傷（TBI）分析の世界市場2022-2031：機会分析・産業予測

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp